REGN
Regeneron Pharmaceuticals, Inc.
$788.04
7.98 (1.00%) Today
— up— down
Ex-Dividend Date
Aug 18, 2026
Aug 18, 2026Open
$788.04
$788.04Previous Close
$796.02
$796.02Day Range
$784.13 – $803.87
$784.13 – $803.8752-Week Range
$541.00 – $859.34
$541.00 – $859.34Volume
592.14K
592.14KExchange
NasdaqGS
NasdaqGSAbout REGN
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.
Related
News
N/AN/AN/AN/AN/A
Gold drops more than 1% on US rate-hike bets - Reuters
Reuters · 2h ago
Dollar firms as US-Iran tensions lift oil, hawkish Fed bets build - Reuters
Reuters · 2h ago
Stocks cautious in Asia as oil gains, yields rise - Reuters
Reuters · 3h ago
Mideast oil exports rebound in September as Saudi Arabia boosts shipments - Reuters
Reuters · 3h ago
Oil heads higher as US-Iran peace talks in stalemate - Reuters
Reuters · 5h ago